Peptides
Kisspeptin-10: A Research Overview
Kisspeptin-10 is the 10-residue C-terminal fragment of kisspeptin, examined in relation to the KISS1R/GPR54 receptor and the GnRH neuroendocrine axis in preclinical models.
Study summaries, compound overviews, and research insights written for researchers who want to understand what the science actually says.
Kisspeptin-10 is the 10-residue C-terminal fragment of kisspeptin, examined in relation to the KISS1R/GPR54 receptor and the GnRH neuroendocrine axis in preclinical models.
KPV is a C-terminal tripeptide fragment of alpha-MSH, examined in relation to melanocortin receptors and NF-κB signaling across preclinical model systems.
Melanotan II is a synthetic cyclic analogue of alpha-MSH, examined in relation to the melanocortin receptor family (MC1R–MC5R) in preclinical models.
Oxytocin is a cyclic nonapeptide hormone, examined in relation to the oxytocin receptor and central neuropeptide signaling across preclinical model systems.
Semaglutide is a GLP-1 receptor agonist peptide, examined in relation to incretin signaling pathways in published literature. An approved drug product exists; material here is research-grade.
Sermorelin is a GHRH(1-29) analogue peptide, examined in relation to the pituitary GHRH receptor and the GH/IGF-1 axis in research settings.
SLU-PP-332 is a small-molecule ERR (estrogen-related receptor) agonist, examined in relation to mitochondrial and oxidative-metabolism gene programs in preclinical models.
Thymosin Alpha-1 (thymalfasin) is a 28-residue thymic peptide, examined in relation to Toll-like receptor and T-cell signaling pathways in published literature.
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide, examined in relation to incretin signaling pathways in published literature. An approved drug product exists; material here is research-grade.
Triptorelin is a GnRH receptor agonist decapeptide, examined in relation to the pituitary GnRH receptor and gonadotropin regulation in research settings.
5-Amino-1MQ is a small-molecule NNMT inhibitor examined in relation to NAD+ and metabolic pathways across preclinical model systems.
AOD-9604 is a modified fragment of the growth-hormone molecule examined in relation to lipid-metabolism pathways in preclinical models.
CJC-1295 with DAC is a long-acting GHRH analogue examined in relation to the GH/IGF-1 axis in preclinical and early-phase research.
CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analogue examined in relation to GH-secretagogue signaling in preclinical models.
GHRP-2 is a synthetic growth-hormone-releasing peptide examined in relation to GHS-R1a receptor signaling in preclinical models.
GHRP-6 is a synthetic growth-hormone-releasing peptide examined in relation to ghrelin-receptor signaling in preclinical models.
Gonadorelin is the synthetic form of gonadotropin-releasing hormone examined in relation to the pituitary GnRH receptor in reproductive-endocrinology research.
Human chorionic gonadotropin is a glycoprotein hormone examined in relation to the LH/CG receptor and steroidogenesis pathways in published literature.
Hexarelin is a synthetic growth-hormone-releasing peptide examined in relation to GHS-R and CD36 receptor signaling in preclinical models.
HGH Fragment 176-191 is a C-terminal fragment of the growth-hormone molecule examined in relation to lipid-metabolism pathways in preclinical models.
Human menopausal gonadotropin is a preparation with FSH and LH activity examined in relation to gonadotropin signaling in reproductive research.
IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 examined in relation to the IGF-1 receptor and cell-growth pathways in preclinical models.
MOTS-C is a mitochondrial-derived peptide studied in relation to metabolic and cellular-energy pathways across preclinical model systems.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist examined across preclinical and clinical pharmacology literature.
Cagrilintide is a long-acting amylin analogue studied in relation to amylin and calcitonin receptor pathways across preclinical and clinical research.
BPC-157 is a synthetic 15 amino acid peptide derived from human gastric juice. Here is what the published research shows about its studied mechanisms and biological activity.
Thymosin Beta-4 is a naturally occurring peptide found in nearly all human cells, examined in relation to actin-binding and cytoskeletal dynamics across preclinical model systems.
NAD+ is a coenzyme involved in hundreds of enzymatic reactions, examined in relation to mitochondrial function, sirtuin signaling, and DNA-damage-response (PARP) pathways in the published literature.
GHK-Cu is a copper-binding tripeptide widely studied in dermatological research, examined in relation to collagen-synthesis, angiogenesis, and antioxidant-response pathways in preclinical models.
Tesamorelin is a GHRH analogue with an extensive published clinical-trial literature, examined in relation to visceral adipose tissue and the GH/IGF-1 axis.
Selank and Semax are synthetic neuropeptides examined in relation to GABAergic signaling and BDNF regulation across preclinical model systems.
Ipamorelin is a selective growth-hormone-releasing peptide (GHRP) examined in relation to GHS-R1a receptor signaling, noted in the literature for its selectivity relative to GHRP-2 and GHRP-6.